NZ’s new disclosure scheme for pharma payments to doctors falls short of best practice
- Written by David Menkes, Associate Professor in Psychological Medicine, University of Auckland, Waipapa Taumata Rau
Getty ImagesPharmaceutical industry payments to doctors are common, often substantial and can affect clinical decision making.
Seven years after the industry trade association Medicines New Zealand first mooted a disclosure system, pharmaceutical companies operating in New Zealand recently revealed their financial relationships with individual...
Hashtag.net.au
